Clinn

CLINN is a digital-first service platform that connects patients in Italy with qualified physicians authorised to prescribe therapeutic cannabis. It focuses on supporting integrated cannabinoid-based medicine for conditions such as chronic pain and other health issues where cannabinoids may offer therapeutic benefit. The platform provides digital tools to coordinate consultations, prescriptions and follow-up monitoring.

Service

CLINN offers medical consultations through a network of licensed physicians who evaluate eligibility for therapeutic cannabis and, when appropriate, issue personalised prescriptions. Prescriptions are filled by partner pharmacies and delivered to the patient’s home. The platform supports treatment for chronic pain and a wide range of other medical areas, including neurological, oncological, rheumatological, musculoskeletal, gastrointestinal, dermatological and psychological conditions.
CLINN also provides a digital follow-up system, allowing patients to track quality of life, sleep quality, pain intensity and anxiety levels through periodic questionnaires. The platform facilitates communication between physicians, pharmacies and patients throughout the treatment process.

Safety

CLINN works exclusively with physicians authorised to prescribe therapeutic cannabis. The service includes ongoing monitoring through its digital platform, allowing clinicians to track clinical outcomes such as pain levels, sleep quality, anxiety and overall wellbeing. Treatment plans are personalised, with specialists tailoring cannabinoid therapy to individual needs. The platform supports secure data handling in accordance with its stated policies.

Care pathway

Patients begin by submitting an online request for a preliminary medical evaluation. A physician from the CLINN network reviews the case and conducts a consultation to determine suitability for cannabinoid therapy. If appropriate, the physician issues a personalised prescription, which is sent to a partner pharmacy for preparation and home delivery. Patients then engage in ongoing digital follow-up through the CLINN platform, completing periodic questionnaires and receiving updates on treatment and prescription status.